Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/1998
08/07/1998CA2222984A1 Novel rat
08/07/1998CA2222978A1 Novel compounds
08/07/1998CA2222961A1 Novel compounds
08/07/1998CA2222957A1 Novel histidine kinase
08/06/1998WO1998033928A1 Live recombinant avian vaccine using the avian infectious laryngotracheitis virus as vector
08/06/1998WO1998033925A1 Glutrnagln amidotransferase - a novel essential translational component
08/06/1998WO1998033904A2 An antisense oligonucleotide preparation method
08/06/1998WO1998033896A2 Microorganisms with increased production of clavulanic acid
08/06/1998WO1998033891A1 Method for the production of selected lymphocytes
08/06/1998WO1998033888A1 Peptides and peptide-loaded antigen presenting cells for the activation of ctl
08/06/1998WO1998033768A1 Arylsulfonylamino hydroxamic acid derivatives
08/06/1998WO1998033524A1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
08/06/1998WO1998033522A1 Infectious bursitis vaccine
08/06/1998WO1998033509A2 Useful properties of human lactoferrin and variants thereof
08/06/1998WO1998033490A2 Use of percaboxylic acids in the control of hairy wart disease
08/06/1998WO1998033482A1 Pain reducing parenteral liposome formulation
08/06/1998WO1998033470A2 Substituted perylenequinones for use in photodynamic therapy
08/06/1998WO1998026768A3 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections and the gastroduodenal diseases associated therewith
08/06/1998WO1998024763A3 Immunotherapeutic imides/amides as pde iv and tnf inhibitors
08/06/1998WO1998021332A3 Secreted proteins and polynucleotides encoding them
08/06/1998WO1998021220A3 Saccharide derivatives
08/06/1998CA2279490A1 Glutrnagln amidotransferase - a novel essential translational component
08/06/1998CA2279259A1 Pain reducing parenteral liposome formulation
08/06/1998CA2279207A1 Novel compounds
08/06/1998CA2278847A1 Method for the production of selected lymphocytes
08/06/1998CA2278824A1 Infectious bursitis vaccine
08/06/1998CA2278189A1 Peptides and peptide-loaded antigen presenting cells for the activation of ctl
08/06/1998CA2277362A1 Substituted perylenequinones for use in photodynamic therapy
08/06/1998CA2222981A1 Promoter of the human endoglin gene and its use
08/05/1998EP0856579A1 An antisense oligonucleotide preparation method
08/05/1998EP0856344A1 Process for purifying imidazoles and imidazol-based agents by crystallisation
08/05/1998EP0856056A1 Fibronectic binding protein b compounds
08/05/1998EP0856051A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
08/05/1998EP0856007A1 Cyclopeptide derivatives
08/05/1998EP0856002A1 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
08/05/1998EP0855919A1 Hormone immunomodulated induction of mucosal immune responses
08/05/1998EP0855918A1 Chicken interleukin-15 and uses thereof
08/05/1998EP0855911A1 Namenamicin, an enediyne antitumor antibiotic from the marine ascidian polysyncraton lithostrotum
08/05/1998EP0698019B1 Novel aromatic nitro compounds and their metabolites useful as anti-viral and anti-tumor agents
08/05/1998EP0690872B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
08/05/1998CN1189857A Recombinant MVA virus, and the use thereof
08/05/1998CN1189840A Hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits
08/05/1998CN1189775A Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
08/05/1998CN1189340A Novel grand spectrum anti-virus application of Gerd mycomycin
08/05/1998CN1039417C 9a-n-(n'-carbamoyl) and 9a-n-(n'-thiocaramoyl) derivatives of 9-deoxo-9a-aza-9a-homoerythromycin A
08/05/1998CA2221687A1 Tumor necrosis related receptor, tr5
08/04/1998US5789573 Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2
08/04/1998US5789567 Chicken infectious anemia virus vaccine
08/04/1998US5789562 Nucleotide monomers containing 8-azapurin bases or a derivative thereof, their preparation and their use in making modified olignonucleotides
08/04/1998US5789549 Genetic engineering; translation
08/04/1998US5789465 Collagen matrix
08/04/1998US5789441 Leukotriene B4 as an antiviral and anti-neoplastic agent
08/04/1998US5789429 Antifungal agents, processes for the preparation thereof, and intermediates
08/04/1998US5789408 Antiviral thiazoles
08/04/1998US5789406 Indeno 1,2-E!pyrazine-4-ones, their preparation and the medicaments containing them
08/04/1998US5789388 Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity
08/04/1998US5789387 Methods and compositions for treating fungal infections in mammals
08/04/1998US5789383 Peptides for treatment of herpes and varicella-zoster
08/04/1998US5789231 Marek's disease vaccine
08/04/1998US5789192 Mammalian receptors for interleukin-10 (IL-10)
08/04/1998US5789177 Glycorproteins, antibodies, and diagnostic kits for detection of bovine herpesvirus type 1
08/04/1998US5788970 Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
08/04/1998US5788969 Peptides for inducing cytotoxic T lymphocyte responses hepatitis B virus
08/04/1998CA2098296C Pseudomonas peptide composition and method for producing the same
08/04/1998CA2087425C 2'-fluorofuranosyl derivatives and novel method of preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides
08/04/1998CA2064634C 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
08/03/1998CA2220852A1 Tumor necrosis related receptor, tr4
07/1998
07/30/1998WO1998032769A1 Antigen
07/30/1998WO1998032768A1 H. pylori antigens
07/30/1998WO1998032766A1 SUBSTITUTED AMINO BICYCLIC-β-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
07/30/1998WO1998032760A1 New carbapenem derivatives
07/30/1998WO1998032738A1 New compounds with hemoregulating effect
07/30/1998WO1998032718A1 New fatty acid derivatives
07/30/1998WO1998032467A2 Method and conjugate for treating h. pylori infection
07/30/1998WO1998032456A1 Identification of broadly reactive dr restricted epitopes
07/30/1998WO1998032446A1 Urease-responsive delivery systems for diagnostic and therapeutic applications
07/30/1998WO1998032442A1 Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids
07/30/1998WO1998032422A1 Pharmaceutical preparations and methods for their regional administration
07/30/1998WO1998017313A3 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
07/30/1998WO1998010787A3 Pharmaceutical compositions for the treatment of immune disorders
07/30/1998DE19703131A1 Verwendung von Chinoxalin in Dreier-Kombination mit Protease-Inhibitoren und Reverse Transkriptaseinhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen Use of quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as drugs for the treatment of AIDS and / or HIV infection
07/30/1998CA2279298A1 New carbapenem derivatives
07/30/1998CA2278924A1 Method and conjugate for treating h. pylori infection
07/30/1998CA2278779A1 Substituted amino bicyclic-.beta.-lactam penam and cepham derivatives as cysteine protease inhibitors
07/30/1998CA2278773A1 Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids
07/30/1998CA2278663A1 Urease-responsive delivery systems for diagnostic and therapeutic applications
07/30/1998CA2278296A1 Identification of broadly reactive dr restricted epitopes
07/29/1998EP0855443A2 cDNA clone HE8CH90 that encodes a 7-transmembrane receptor
07/29/1998EP0855183A2 Manufacture of taste-masked preparations of antibacterial quinolone derivatives
07/29/1998EP0854925A1 THE NucA PROTEIN OF $i(HAEMOPHILUS INFLUENZAE) AND THE GENE ENCODING THAT PROTEIN
07/29/1998EP0854922A1 Improvements in or relating to protection against intracellular infection
07/29/1998EP0854875A1 New cephem compounds
07/29/1998EP0854874A1 Macrocyclic lactone compounds and their production process
07/29/1998EP0854870A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity
07/29/1998EP0854860A1 A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same
07/29/1998EP0854730A1 High affinity human monoclonal antibodies specific for rsv f-protein
07/29/1998EP0854729A1 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
07/29/1998EP0854722A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods
07/29/1998EP0854715A1 Methods of inhibiting plasminogen activator inhibitor 1
07/29/1998EP0854711A1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR
1 ... 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 ... 1798